https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

INCB057643 in Combination with Ruxolitinib Improves Symptoms in Patients With Myelofibrosis

INCB057643 in Combination with Ruxolitinib Improves Symptoms in Patients With Myelofibrosis

INCB057643 shows promise in treating myelofibrosis, enhancing anemia and symptom relief.

administrator

Related Articles